Spring sale! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ads free!Spring sale! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ads free today!Spring sale! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
Business
Football
Sport
Entertainment
Tech
Science

Moderna
Biotech
mRNA
Moderna Vaccine
Gilead Sciences
Topics

Advertisement

Moderna

Share

Top Latest Popular

🐣 SPRING SALE! Go ads free in 2026, with NewsNow Essentials for just £2.99 a month!

🐣 SPRING SALE! Stay informed ads free in 2026, with NewsNow Essentials for just £2.99 a month! Upgrade today!

Moderna's Q1 revenues rocket, thanks to ex-US sales pharmaphorum 8d

pharmaphorum 8d

Phase 3 trial finds Moderna mRNA flu vaccine outperforms standard vaccine in older adults Center for Infectious Disease Research and Policy 1d

Center for Infectious Disease Research and Policy 1d

Moderna Vaccine mRNA

Moderna’s mRNA flu vaccine more effective than current SoC Clinical Trials Arena 18h

Clinical Trials Arena 18h

Advertisement

Advertisement

CureVac patent suit targets Moderna’s spikevax Covid-19 shots Bloomberg Law 17:57 Mon, 27 Apr

Bloomberg Law 17:57 Mon, 27 Apr

Moderna Vaccine Coronavirus Vaccine

Moderna first-quarter revenue jumps on strong overseas COVID vaccine sales The Economic Times 7d

The Economic Times 7d

Moderna Vaccine Coronavirus Vaccine

Moderna gears up to report Q1 earnings: Here's what to expect Zacks 14:21 Tue, 28 Apr

Zacks 14:21 Tue, 28 Apr

Advertisement

Advertisement

Latest

In the last 8 hours

Moderna (MRNA) Shares Skyrocket, What You Need To Know Barchart 21:27 Fri, 08 May

MRNA Stock Alert: Moderna Surges on Hantavirus Vaccine Hopes Barchart 21:07 Fri, 08 May

Yesterday

Moderna flags work on hantavirus vaccines before cruise outbreak Boston Globe 18:53 Fri, 08 May

Moderna Stock Rises On Positive Phase 3 Flu Data: What Investors Need To Know Benzinga 14:35 Fri, 08 May

Moderna’s mRNA flu vaccine more effective than current SOC Clinical Trials Arena 10:20 Fri, 08 May

Thursday

Moderna, Vir among early 2026 top infectious disease gainers BioWorld 21:50 Thu, 07 May

Phase 3 trial finds Moderna mRNA flu vaccine outperforms standard vaccine in older adults Center for Infectious Disease Research and Policy 18:28 Thu, 07 May

Moderna Stock Gives Back Early Gains: What's Happening? Benzinga 16:06 Thu, 07 May

Moderna Reaches Analyst Target Price Nasdaq 12:17 Thu, 07 May

Wednesday

Is Wall Street Bullish or Bearish on Moderna Stock? Barchart 23:19 Wed, 06 May

Advertisement

Advertisement

Advertisement

About our Moderna news

Latest news on Moderna, a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Industry Sectors Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna